Health
Cannabinoid pathways may offer targets for kidney disease as CKD affects 850 million people
Approximately 850 million people globally (9.1% of the world's population) have chronic kidney disease (CKD). The number of affected individuals has grown steadily during the past 20 years and is on track to continue rising.
AI Summary
Chronic kidney disease (CKD) affects a significant portion of the global population, with approximately 850 million people worldwide impacted. The condition has been steadily increasing over the past 20 years, and current treatments, such as RAAS inhibitors and angiotensin receptor blockers, have varying levels of effectiveness. Research suggests that cannabinoid pathways may offer potential targets for addressing CKD, providing a new area of exploration for treatment options.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- A deadly fungus may not live to see the last of usContinue reading
- Wearable stroke rehabilitation device gives patients the upper handContinue reading
- Call for the WHO to declare the climate crisis a public health emergency of international concernContinue reading
- Case report highlights multidisciplinary approach to recurrent prostate cancerContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow